Citation Impact
Citing Papers
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
Neurofascin as a novel target for autoantibody-mediated axonal injury
2007
IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum
2010
Human MxA Protein: An Interferon-Induced Dynamin-Like GTPase with Broad Antiviral Activity
2010
Pathologic heterogeneity persists in early active multiple sclerosis lesions
2014
High field MRI in the diagnosis of multiple sclerosis: high field–high yield?
2009
Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis
2007
DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population
1998
Plasma Exchange in Neuroimmunological Disorders
2006
Plasma phospholipids identify antecedent memory impairment in older adults
2014
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
2010 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
2019 StandoutNatureNobel
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
Disruption of neurofascin localization reveals early changes preceding demyelination and remyelination in multiple sclerosis
2006
Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection
2007
Astrocytes and Microglia as Major Players of Myelin Production in Normal and Pathological Conditions
2020
Choosing anticancer drug targets in the postgenomic era
1999 StandoutNobel
A microRNA component of the p53 tumour suppressor network
2007 StandoutNature
Imaging of multiple sclerosis: Role in neurotherapeutics
2005
Guillain-Barré syndrome
2016 Standout
Optic nerve diffusion changes and atrophy jointly predict visual dysfunction after optic neuritis
2009
Decreased Prefrontal Myo-Inositol in Major Depressive Disorder
2005
Severe Sepsis and Septic Shock
2013 Standout
CCR1+/CCR5+ Mononuclear Phagocytes Accumulate in the Central Nervous System of Patients with Multiple Sclerosis
2001
Evolution of the blood–brain barrier in newly forming multiple sclerosis lesions
2011
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
2008 Standout
Multiple sclerosis
2008 Standout
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
2008
Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis
2007
Prospective study on the relationship between infections and multiple sclerosis exacerbations
2002
Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time
2002
Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study
2004
Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research
2006
Cytomegalovirus Infection Following Liver Transplantation: Review of the Literature
1996
The pathology of primary progressive multiple sclerosis
2004
Ankylosing spondylitis
2007 Standout
Effect of interferon-?1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: Results of a European multicenter, randomized, double-blind, placebo-controlled trial
1999
Intra‐articular depot formulation principles: Role in the management of postoperative pain and arthritic disorders
2008
From endoplasmic-reticulum stress to the inflammatory response
2008 StandoutNature
Alzheimer's disease
2016 Standout
Sickle-cell disease
2010 Standout
Molecular mechanisms of axonal damage in inflammatory central nervous system diseases
2003
Genetics of primary progressive multiple sclerosis
2014
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
Major Depressive Disorder
2008 Standout
Multiple Sclerosis — The Plaque and Its Pathogenesis
2006
The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade(R))
2004
Role of chemokines and their receptors in the pathogenesis of multiple sclerosis
2004
The role of nitric oxide in multiple sclerosis
2002
Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis
2008
Multiple Sclerosis
2000 Standout
A role for oligodendrocyte‐derived IGF‐1 in trophic support of cortical neurons
2001
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Associations of Tumor Necrosis Factor α and HLA Polymorphisms with Adult Dermatomyositis: Implications for a Unique Pathogenesi1
2002
Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration
2010
Relationship of Apolipoprotein E and Age at Onset to Parkinson Disease Neuropathology
2006
The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration
2006
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Genetic Polymorphisms in Sepsis
2011
Infection in Solid-Organ Transplant Recipients
2007 Standout
Polymyositis and dermatomyositis
2003 Standout
Cytokine producing CD8+ T cells are correlated to MRI features of tissue destruction in MS
2003
Moyamoya Disease and Moyamoya Syndrome
2009 Standout
A novel form of Epstein-Barr virus latency in normal B cells in vivo
1995 Standout
Amyotrophic Lateral Sclerosis
2001 Standout
Infection in Organ-Transplant Recipients
1998 Standout
Biomarkers in multiple sclerosis
2015
Chemokine receptors: multifaceted therapeutic targets
2002
Multiple sclerosis
2002 Standout
The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)
2002
Epstein–Barr Virus Infection
2000 Standout
B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation
2006
The Many Roles of Chemokines and Chemokine Receptors in Inflammation
2006 Standout
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
2006 Standout
Defects in the Ubiquitin Pathway Induce Caspase-independent Apoptosis Blocked by Bcl-2
1998 StandoutNobel
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection
1996
Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis
2008
Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS
2001
The Bcl-2 Protein Family: Arbiters of Cell Survival
1998 StandoutScience
Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis
1999
Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease
2002
Neuropathology in multiple sclerosis: new concepts
1998
Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders
1997
Accelerated Macrophage Apoptosis Induces Autoantibody Formation and Organ Damage in Systemic Lupus Erythematosus
2006
In Vivo Downregulation of T Helper Cell 1 Immune Responses Reduces Atherogenesis in Apolipoprotein E-Knockout Mice
2001
Nuclear magnetic resonance monitoring of treatment and prediction of outcome in multiple sclerosis
1999
Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients
1994
Cancer Cell Cycles
1996 StandoutScience
Multiple Sclerosis
2018 Standout
A serial study of new MS lesions and the white matter from which they arise
1998
Advances in leishmaniasis
2005 Standout
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
Multiple sclerosis: Brain-infiltrating CD8+T cells persist as clonal expansions in the cerebrospinal fluid and blood
2004
Electrochemiluminescence (ECL)
2004 Standout
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Association between the Tumor Necrosis Factor Locus and the Clinical Outcome ofLeishmania chagasiInfection
2002
Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions
2016
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
2000 StandoutScience
Monitoring of Epstein-Barr Virus DNA Load in Peripheral Blood by Quantitative Competitive PCR
1999
Role of MRI in the differentiation of ADEM from MS in children
2008
Multiple Epstein-Barr Virus Infections in Healthy Individuals
2003
Levels of Soluble Adhesion Molecules Are Elevated in the Cerebrospinal Fluid of Children with Moyamoya Syndrome
2002
Molecular mechanisms of axonal damage in inflammatory central nervous system diseases
2003
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
2008 StandoutNobel
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking
2002
The pathology of primary progressive multiple sclerosis
2002
Superparamagnetic Iron Oxide Nanoparticles: Diagnostic Magnetic Resonance Imaging and Potential Therapeutic Applications in Neurooncology and Central Nervous System Inflammatory Pathologies, a Review
2009
Nitric oxide prevents axonal degeneration by inducing HIF-1–dependent expression of erythropoietin
2011 StandoutNobel
Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain
2011 StandoutNobel
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
2017 StandoutNobel
Randomized, double-blind, dose-comparison study of glatiramer acetate in relapsing–remitting MS
2007
Works of Andreas Bitsch being referenced
Cytomegalovirus Transcripts in Peripheral Blood Leukocytes of Actively Infected Transplant Patients Detected by Reverse Transcription-Polymerase Chain Reaction
1993
Analysis of interleukin-4 receptor α chain variants in multiple sclerosis
2001
The relative number of macrophages/microglia expressing macrophage colony‐stimulating factor and its receptor decreases in multiple sclerosis lesions
2002
Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology
1997
Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis
1996
Autoantibody synthesis in primary progressive multiple sclerosis patients treated with interferon beta-1b
2004
Tumour necrosis factor alpha mRNA expression in early multiple sclerosis lesions: Correlation with demyelinating activity and oligodendrocyte pathology
2000
Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange
2005
MxA protein – an interferon beta biomarker in primary progressive multiple sclerosis patients
2008
A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions
2001
Synergistic immunomodulatory effects of interferon‐β1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing‐remitting multiple sclerosis
1998
Identification of macrophage populations expressing tumor necrosis factor-α mRNA in acute multiple sclerosis
1998
Acute axonal injury in multiple sclerosis: Correlation with demyelination and inflammation
2000
Costs and quality of life in multiple sclerosis
2001
Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production.
1996
Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy.
1999
A Longitudinal Prospective Study of Soluble Adhesion Molecules in Acute Stroke
1998
Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions
1999
Lesion development in Marburg's type of acute multiple sclerosis: from inflammation to demyelination
1999
Effects of low-dose, noncytotoxic, intraarticular liposomal clodronate on development of erosions and proteoglycan loss in established antigen-induced arthritis in rabbits
2001
Detection and quantification of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction
1992